VGXI Blog & News
Welcome to the VGXI blog where we examine scientific trends, innovation, technological advancements in plasmid DNA manufacturing, and uncover how next-generation therapeutics are shaping the future of medicine and improving patients’ lives.
VGXI, Inc. Names Jeff Whitmore as New Chief Commercial Officer
Leading plasmid DNA CDMO VGXI, Inc. announces the appointment of Jeff Whitmore as its new Chief[…]
Read More
VGXI Celebrates the Grand Opening for its New Headquarters and Manufacturing Facility
With original operations based in The Woodlands, TX, industry recognized plasmid DNA contract[…]
Read More
An Introduction to DNA and Vaccines
Vaccines are one of humanity’s most important inventions as they help protect public health[…]
Read More
VGXI Announces Grand Opening Celebration for New Headquarters and Manufacturing Facility
Specialized plasmid DNA contract manufacturer VGXI, Inc. announces date for the Grand Opening[…]
Read More
VGXI Celebrates First Look Event at New Manufacturing Facility
VGXI opened the doors of its new headquarters and manufacturing facility on 09Apr22 to provide[…]
Read More
VGXI Official COVID-19 Statement
To our Valued Clients and Business Partners, VGXI’s top priority is to continue delivering[…]
Read More
VGXI Partner IMM Announces $12M NIH Grant to Support Phase 1 Clinical Trial of a DNA Vaccine for the Prevention of Alzheimer’s Disease
Texas-based CDMO VGXI, Inc. is excited to announce that its partner, The Institute for[…]
Read More
VGXI New Manufacturing Facility Achieves Construction Milestones In Advance of 2022 Operational Date
Specialized GMP contract manufacturer VGXI, Inc. announced multiple construction milestones[…]
Read More
VGXI, Inc. Partners with Rare Trait Hope Fund in Support of Gene Therapy for Rare Disease, AGU
Industry leading plasmid DNA Manufacturer VGXI, Inc. partners with Rare Trait Hope Fund in[…]
Read More
